Boehringer In­gel­heim per­ma­nent­ly shelves pro­duc­tion of cloni­dine, cit­ing ear­li­er re­call and mar­ket com­peti­tors

One less ver­sion of cloni­dine, the decades-old blood pres­sure and AD­HD drug, is now on the shelves.

Boehringer In­gel­heim will dis­con­tin­ue its pro­duc­tion of Cat­apres …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.